The most common molecular subtypes of GIST harbor KIT exon 11 mutations, occurring in ∼53-61% of all cases, or PDGFRA exon 18 mutations, found in 13-14% of patients (Wozniak et al., 2014; Blay et al., 2021). This evidence concerns the gene KIT and gastrointestinal stromal tumor.